APLM
Apollomics Inc. Class A Ordinary Shares
NASDAQ: APLM · HEALTHCARE · BIOTECHNOLOGY
$13.08
+1.75% today
Updated 2026-04-29
Market cap
$28.71M
P/E ratio
—
P/S ratio
3.19x
EPS (TTM)
$-7.57
Dividend yield
—
52W range
$4 – $40
Volume
0.0M
Apollomics Inc. Class A Ordinary Shares (APLM) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $79.05M | $169.94M | $123.44M | $76.47M | $55.39M | $13.10M |
| Cash & equivalents | $38.49M | $130.65M | $46.74M | $32.67M | $32.06M | $9.77M |
| Current assets | $75.43M | $156.71M | $99.37M | $55.79M | $39.92M | $10.27M |
| Total liabilities | $139.78M | $297.87M | $336.30M | $524.60M | $14.15M | $8.23M |
| Current liabilities | $4.58M | $12.08M | $13.56M | $12.36M | $13.56M | $7.40M |
| Long-term debt | — | — | — | — | — | — |
| Shareholder equity | $-60.72M | $-127.93M | $-212.86M | $-448.12M | $41.23M | $4.86M |
| Retained earnings | $-66.73M | $-141.54M | $-235.44M | $-474.60M | $-646.97M | $-700.82M |
| Accounts receivable | $361000.00 | $415000.00 | $506000.00 | $547000.00 | $466000.00 | $127000.00 |
| Inventory | — | $950000.00 | $2.25M | — | $-466000.00 | — |
| Goodwill | — | — | — | — | — | — |